Plus Therapeutics Inc (PSTV)
1.18
-0.02
(-1.67%)
USD |
NASDAQ |
Nov 22, 16:00
1.20
+0.02
(+1.69%)
After-Hours: 20:00
Plus Therapeutics Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 6.963M |
| March 31, 2024 | -0.776M |
| December 31, 2023 | -0.529M |
| September 30, 2023 | 2.52M |
| June 30, 2023 | 0.961M |
| March 31, 2023 | 0.493M |
| December 31, 2022 | 0.099M |
| September 30, 2022 | 6.431M |
| June 30, 2022 | -0.371M |
| March 31, 2022 | 7.292M |
| December 31, 2021 | -0.258M |
| September 30, 2021 | 6.374M |
| June 30, 2021 | 5.109M |
| March 31, 2021 | 9.191M |
| December 31, 2020 | 4.00M |
| September 30, 2020 | 0.673M |
| June 30, 2020 | -4.974M |
| March 31, 2020 | -0.018M |
| December 31, 2019 | -0.259M |
| September 30, 2019 | 14.42M |
| June 30, 2019 | -3.425M |
| March 31, 2019 | 1.891M |
| December 31, 2018 | 0.922M |
| September 30, 2018 | 6.446M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.05M |
| March 31, 2018 | -0.15M |
| December 31, 2017 | 9.158M |
| September 30, 2017 | -0.028M |
| June 30, 2017 | 8.02M |
| March 31, 2017 | -0.335M |
| December 31, 2016 | 1.681M |
| September 30, 2016 | -0.477M |
| June 30, 2016 | 16.34M |
| March 31, 2016 | 0.062M |
| December 31, 2015 | -0.054M |
| September 30, 2015 | 1.319M |
| June 30, 2015 | 15.75M |
| March 31, 2015 | 3.779M |
| December 31, 2014 | 11.70M |
| September 30, 2014 | 2.668M |
| June 30, 2014 | 9.614M |
| March 31, 2014 | 6.895M |
| December 31, 2013 | 14.98M |
| September 30, 2013 | -0.039M |
| June 30, 2013 | 5.494M |
| March 31, 2013 | 0.332M |
| December 31, 2012 | 16.53M |
| September 30, 2012 | -0.033M |
| June 30, 2012 | 0.477M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.974M
Minimum
Jun 2020
9.191M
Maximum
Mar 2021
2.146M
Average
0.583M
Median
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| InfuSystems Holdings Inc | -6.752M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.68M |
| Cash from Investing (Quarterly) | -0.009M |
| Free Cash Flow | -11.95M |
| Free Cash Flow Per Share (Quarterly) | -0.4702 |
| Free Cash Flow Yield | -147.7% |